Incorporated in 1968, Blue Jet Healthcare Limited is a speciality pharmaceutical and healthcare ingredients and intermediates company. The company’s operations are organised into 3 product categories such as contrast media intermediates, high-intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients.
The company operates its business through a contract development and manufacturing organisation (CDMO) business model. The business model is backed with specialised chemistry capabilities in high-intensity sweeteners and contrast media intermediates. This is supported by strategic and early investments in research and development (R&D) and manufacturing infrastructure.
The company believes that the overall contrast media formulations market is forecast to grow at a CAGR of 6-8% during 2023-2025. The growth is expected to be mainly supported by volume. The growth drivers for contrast media primarily include growing population and changing demographics, rising healthcare expenditure, focus on early diagnosis, and increased convenience, etc.
Blue Jet Healthcare Limited IPO Details
Blue Jet Healthcare Limited IPO Date
Blue Jet Healthcare Limited's IPO is a 100% offer for sale (OFS). The OFS comprises 2,42,85,160 shares aggregating up to ₹840.27 Cr. Blue Jet Healthcare Limited’s IPO will be listed on the BSE and NSE on October 27, 2023. It is a book-built issue IPO.
Blue Jet Healthcare Limited IPO Price Band
The price range of the IPO has been fixed at ₹329 to ₹346 per share.
Blue Jet Healthcare Limited IPO Lot Size
The Blue Jet Healthcare Limited IPO lot size is 43 shares, and the minimum investment will be ₹14,878.
Blue Jet Healthcare Limited IPO Objectives
As the issue is a 100% OFS, meaning the entire issue proceeds will go to the selling shareholder, and Blue Jet will not get any amount from the offer.
Peer Details
As per DRHP, Blue Jet Healthcare Limited has no listed peers.
How To Check the Allotment Status of the Blue Jet Healthcare Limited IPO?
Steps to check IPO allotment status on Angel One’s app:
- Log in to the Angel One app
- Go to the IPO Section and then to IPO Orders
- Select the individual IPO that you had applied for and check the allotment status.
- Angel One will notify you of your IPO allotment status via push notification and email.
Contact Details of Blue Jet Healthcare Limited
Registered office: 701, 702, 7th Floor, Bhumiraj Costarica, Sector
18, Sanpada, Navi Mumbai, Thane – 400 705, Maharashtra, India
Phone: +91 (22) 6989 1200
E-mail:Companysecretary@bluejethealthcare.com
Blue Jet Healthcare Ltd. CompanyFinancials
| Particulars | Period Ending on March 31, 2021 ( ₹ Cr ) | Period Ending on June 30, 2023 ( ₹ Cr ) | Period Ending on March 31, 2023 ( ₹ Cr ) |
|---|---|---|---|
| Total Income | 507.81 | 184.60 | 744.94 |
| Profit After Tax (PAT) | 135.79 | 44.12 | 160.03 |
| Assets | 536.27 | 903.80 | 862.07 |
Know before investing
Strengths
2The company is the largest manufacturer of contrast media intermediates in India. It manufactures contrast media intermediates and supplies a critical starting intermediate and several advanced intermediates primarily to 3 of the largest contrast media manufacturers in the world, including GE Healthcare.
The company holds a notable presence in niche categories with high barriers to entry primarily due to the strict internal standards of contrast media manufacturers for feature and impurity profiles.
Risks
2The company is highly dependent on Europe (EU) and the United States (US) for a significant portion of its revenue from operations. These are highly regulated markets. Any failure in fulfilling compliances could impact the business growth.
The company is exposed to counterparty credit risk, and any delay in receiving payments or non-receipt of payments may adversely impact its results of operations.
